𝔖 Bobbio Scriptorium

✦ LIBER ✦

Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide as Primary Systemic Treatment in Elderly Breast Cancer Patients

✍ Scribed by Burstein, H.J.

Book ID: 122873414
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 111 KB
Volume: 18
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(07)80089-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin plus cyclophosphamide vs. wee

Epirubicin plus cyclophosphamide vs. weekly paclitaxel as primary systemic therapy in patients with stage II and III breast cancer: randomized phase II study

✍ M. Miyashita; Kohno; S. Takao; K. Wakita; M. Konishi; H. Yoshimura; M. Kubota; Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 136 KB

P.39 Docetaxel plus epirubicin (DE) vs d

P.39 Docetaxel plus epirubicin (DE) vs docetaxel plus capecitabine (DC) as 1st line treatment in patients with locally advanced and metastatic breast cancer: a subgroup analysis for elderly patients of a multicenter randomized phase III trial from the Hellenic Oncology Research Group (HORG)

✍ Vamvakas, L.; Karampeazis, A.; Ardavanis, A.; Souglakos, I.; Kalbakis, K.; Varda 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB